Skip to main content

Table 5 Associations of serum levels of ALT with the prevalence of NAFLD

From: Joint associations of serum uric acid and ALT with NAFLD in elderly men and women: a Chinese cross-sectional study

ALT levels Cases/n (%) Model 1 Model 2
OR 95% CI P OR 95% CI P
Total (n = 7569)
Q1 227/1899 (12.0) 1    1   
Q2 496/2259 (22.0) 2.09 1.76–2.48 < 0.001 1.54 1.26–1.87 < 0.001
Q3 482/1560 (30.9) 3.37 2.83–4.03 < 0.001 2.18 1.77–2.69 < 0.001
Q4 1024/1851 (55.3) 9.39 7.93–11.1 < 0.001 4.96 3.98–6.17 < 0.001
Men (n = 3126)
Q1 117/921 (12.7) 1    1   
Q2 153/684 (22.4) 1.93 1.48–2.52 < 0.001 1.38 1.02–1.86 0.04
Q3 264/805 (32.8) 3.16 2.47–4.04 < 0.001 2.03 1.53–2.68 < 0.001
Q4 433/716 (60.5) 9.51 7.42–12.2 < 0.001 4.76 3.47–6.53 < 0.001
Women (n = 4443)
Q1 160/1314 (12.2) 1    1   
Q2 188/924 (20.3) 1.85 1.47–2.32 < 0.001 1.44 1.11–1.88 0.006
Q3 401/1213 (33.1) 3.62 2.95–4.44 < 0.001 2.80 2.21–3.55 < 0.001
Q4 513/992 (51.7) 7.99 6.49–9.84 < 0.001 5.53 4.19–7.30 < 0.001
  1. For all participants: Q1, < 14 U/L; Q2, 14–18 U/L; Q3, 19–24 U/L; Q4, ≥ 25 U/L
  2. For men: Q1, < 16 U/L; Q2, 16–19 U/L; Q3, 20–27 U/L; Q4, ≥ 28 U/L
  3. For women: Q1, < 14 U/L; Q2, 14–16 U/L; Q3, 17–23 U/L; Q4, ≥ 24 U/L
  4. Model 1: adjusted for age and sex (just for all participants)
  5. Model 2: adjusted for age, sex (only for all participants), BMI, history of cardiovascular related diseases, DBP, AST, TG, TC, HDL and FPG